Prognostic value of c-erbB2 overexpression in axillary lymph node positive breast cancer. Results from a randomized adjuvant treatment protocol
Open Access
- 1 December 1994
- Vol. 74 (11), 2956-2963
- https://doi.org/10.1002/1097-0142(19941201)74:11<2956::aid-cncr2820741111>3.0.co;2-v
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Prognostic significance of HER-2 oncoprotein expression in breast cancer: a 30-year follow-up.Journal of Clinical Oncology, 1992
- Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.Journal of Clinical Oncology, 1992
- Human breast cancer: prognostic significance of the c-erbB-2 oncoprotein compared with epidermal growth factor receptor, DNA ploidy, and conventional pathologic features.Journal of Clinical Oncology, 1992
- c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodesBritish Journal of Cancer, 1991
- Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer.Journal of Clinical Oncology, 1990
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989
- Randomized trial to evaluate the addition of tamoxifen to cyclophosphamide, 5-fluorouracil, prednisone adjuvant therapy in premenopausal women with node-positive breast cancerCancer, 1989
- Neu-Protein Overexpression in Breast CancerNew England Journal of Medicine, 1988
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958